Popular on Innoget
Publications
- View more
 | Seeking Oral Care Solutions with Seal and Protect Benefit |
|
Products, technologies or ingredients that (a) provide a layer, barrier or coating which will inhibit the formation of plaque or biofilm on tooth surfaces and/or (b) provide a coating to protect the teeth from stain and erosive acids or deliver effective amounts of oral care ingredient for an extended period of time. |
| | Seeking Gum Health Solutions |
|
is for products, technologies, or ingredients that reverse receding gums and/or heal and rebuild gum tissue. We are looking for products, technologies or ingredients that can improve overall health and appearance of gums. |
| | Seeking Solutions for Repair and Protection of Enamel and Dentin |
|
A product that delivers significant and long lasting repair to damaged tooth enamel and dentin |
 | Smart bench for ambulances and air-ambulances |
|
The Department of Nursing of the University of Alicante has designed a new ambulances platform, which in addition to the current functions of the platforms allocating the stretchers in vehicles, provides the exact value of the weight of the patient, in real time, facilitating the calculation of precise doses of drugs, fluids, mechanical ventilation, etc. This platform has digitals sensors placed parallel along its lower side bars, connected to a digital transmitter and a screen via bluetooth or Wi-Fi. The design of the electronic device can be configured in a basic mode, just showing the weight of the patient allowing to health professionals to better calculate the correct doses of drugs, etc., by themselves; or its advanced mode, also detailing the exact dose of drugs, fluids, parameters of invasive mechanical ventilation, amount of energy, etc., automatically calculated with an integrated software. Companies interested in the commercial exploitation of the invention through a patent license agreement are sought. |
 | Exon skipping by CRISPR-Cas9 editing for Duchenne muscular dystrophy |
|
Background Duchenne muscular dystrophy (DMD) is a rare, severe genetic disease characterized by progressive muscle wasting. It is caused by mutations in DMD gene that prevent the production of the muscle isoform of dystrophin protein. The symptom onset is usually in early childhood and life expectancy is ~30 years. Elevidys is currently the only gene therapy approved for DMD, which is designed to deliver a gene coding for a shorter version of dystrophin. This approach was taken because delivery of the whole DMD gene is challenging as it is the largest human gene. Antisense oligonucleotide medications for exon skipping (exons 45, 51, and 53) to produce a shorter yet functional dystrophin gene have been approved, which require periodic administration. None of the drugs is suitable for all DMD patients. More treatment solutions are urgently needed. |
| | Biometric identification system based on eye blinking |
|
The Optics and Vision Sciences research group at the University of Alicante has developed a method for biometric authentication by recognizing the blinking of a subject. The method consists of studying and characterizing the changes in the intensity of diffused light during the blinking process. Those changes are used to classify the blinks using different algorithms. A subject can then be identified according to the parameters recorded. This method allows the authentication of subjects by means of a non-contact procedure, and even unconsciously. Commercial or built-in on mobile devices video cameras or webcams can be used for its application provided that the video is recorded at rates higher than 150 frames per second (fps). We are looking for companies interested in the commercial exploitation of this technology as well as in adapting it for the development of related projects. |
Job opportunities
Introducing Innoget Jobs
Great innovation projects are built with
talented and creative people.
